Name: Dr Barry Davis
AstraZeneca

Events this person is speaking at:

Monday 2 November 2015

Development of AZD5363, an inhibitor of AKT with activity in tumours containing mutations in the P13K-AKT pathway
Date: 2 November 2015, 11:00 - 12:00
Speaker : Dr Barry Davis ( AstraZeneca)
Venue: Old Road Campus Research Building, Headington OX3 7DQ
Venue Details: 71A, B and C
Organiser: Linda Nemerofksy-Birks (University of Oxford)
Host: Anderson Ryan (University of Oxford )